FRAZIER MANAGEMENT LLC - Q4 2017 holdings

$617 Million is the total value of FRAZIER MANAGEMENT LLC's 9 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 12.5% .

 Value Shares↓ Weighting
ANAB  ANAPTYSBIO INC$371,500,000
+188.2%
3,688,4480.0%60.25%
+31.1%
RXDX BuyIGNYTA INC$58,038,000
+116.2%
2,173,693
+0.0%
9.41%
-1.7%
FOLD  AMICUS THERAPEUTICS INC$37,414,000
-4.6%
2,600,0140.0%6.07%
-56.6%
COLL  COLLEGIUM PHARMACEUTICAL INC$34,840,000
+76.0%
1,887,3320.0%5.65%
-20.0%
ALNA NewALLENA PHARMACEUTICALS INC$33,504,0003,330,373
+100.0%
5.43%
SRRA  SIERRA ONCOLOGY INC$30,258,000
+140.6%
8,112,1210.0%4.91%
+9.4%
ALPN  ALPINE IMMUNE SCIENCES INC$24,629,000
-3.4%
2,199,0110.0%3.99%
-56.1%
IOVA  IOVANCE BIOTHERAPEUTICS INC$17,507,000
+3.2%
2,188,3310.0%2.84%
-53.1%
CDTX  CIDARA THERAPEUTICS INC$8,923,000
-16.1%
1,312,2580.0%1.45%
-61.8%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-02-13
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
COLLEGIUM PHARMACEUTICAL INC21Q4 202037.0%
ANAPTYSBIO INC20Q4 202163.7%
CIDARA THERAPEUTICS INC20Q3 202017.2%
IOVANCE BIOTHERAPEUTICS INC19Q4 202113.7%
ALLENA PHARMACEUTICALS INC18Q1 202211.9%
ALPINE IMMUNE SCIENCES INC18Q4 20219.1%
APTINYX INC15Q4 202116.9%
KRYSTAL BIOTECH INC14Q4 20219.7%
GRITSTONE ONCOLOGY INC14Q4 20218.2%
SIERRA ONCOLOGY INC12Q4 20196.6%

View FRAZIER MANAGEMENT LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2022-11-14
13F-HR2022-08-10
13F-HR2022-05-13
13F-HR2022-02-08
13F-HR2021-11-12
13F-HR2021-08-11
13F-HR2021-05-12
13F-HR2021-02-11
13F-HR2020-11-12
13F-HR2020-08-04

View FRAZIER MANAGEMENT LLC's complete filings history.

Compare quarters

Export FRAZIER MANAGEMENT LLC's holdings